A method of treating or preventing skin yeast infections, such as cutaneous candidiasis, includes applying a polymerizable monomer adhesive composition to an area of skin afflicted with or susceptible to a skin yeast infection, optionally with at least one of an additional anti-fungal agent or a ski
A method of treating or preventing skin yeast infections, such as cutaneous candidiasis, includes applying a polymerizable monomer adhesive composition to an area of skin afflicted with or susceptible to a skin yeast infection, optionally with at least one of an additional anti-fungal agent or a skin care additive, and allowing the polymerizable monomer composition to polymerize to form a polymer film over the area of skin.
대표청구항▼
1. A method of treating a skin yeast infection, comprising:a) applying an adhesive composition comprising a polymerizable monomer to an area of skin that is afflicted with a skin yeast infection; and b) allowing said polymerizable monomer composition to polymerize to form a polymer film over said ar
1. A method of treating a skin yeast infection, comprising:a) applying an adhesive composition comprising a polymerizable monomer to an area of skin that is afflicted with a skin yeast infection; and b) allowing said polymerizable monomer composition to polymerize to form a polymer film over said area of skin wherein said polymerizable monomer composition is an α-cyanoacrylate monomer. 2. The method of claim 1, wherein said method is for treating said skin yeast infection, and said area of skin is afflicted with said skin yeast infection.3. The method of claim 1, wherein said polymerizable monomer composition comprises a 1,1-disubstituted ethylene monomer.4. The method of claim 1, wherein said monomer composition comprises at least one member selected form the group consisting of ethyl cyanoacrylate, butyl cyanoacrylate, and 2-octyl cyanoacrylate.5. The method of claim 1, further comprising combining at least one of an anti-fungal agent or a skin care additive with the polymerizable monomer composition on the area so that the at least one agent or additive serves as a polymerization initiator for said polymerizable monomer composition.6. The method of claim 1, wherein said composition further comprises at least one stabilizing agent for said polymerizable monomer.7. The method of claim 6, wherein said stabilizing agent is also at least one of an anti-fungal agent or a skin care additive.8. The method of claim 1, wherein said composition comprises at least one plasticizer.9. The method of claim 8, wherein the plasticizer is selected from the group consisting of tributyl citrate, acetyl tributyl citrate, polymethylmethacrylate, polydimethylsiloxane and hexadimethylsilazane.10. The method of claim 1, wherein the composition further comprises at least one of an anti-fungal agent or a skin care additive.11. The method of claim 10, wherein said method is for treating said skin yeast infection, and said area of skin is afflicted with said skin yeast infection.12. The method of claim 10, wherein the composition further comprises said at least one anti-fungal agent and said at least one anti-fungal agent is selected from the group consisting of parabens, cresols, azoles, allylamines, pollyenes, acidics, mercurials, quaternary ammonium compounds, and non-polymer-stabilized compounds.13. The method of claim 10, wherein the composition further comprises said at least one anti-fungal agent and said at least one anti-fungal agent is a paraben selected from the group consisting of alkyl parabens having an alkyl group of from 1-4 carbon atoms.14. The method of claim 10, wherein the composition further comprises said at least one anti-fungal agent and said at least one anti-fungal agent is selected from the group consisting of methylparaben, methylparaben sodium, ethylparaben, propylparaben, propylparaben sodium, butylparaben, cresol, chlorocresol, voriconazole, ketoconazole, fluconazole, itraconazole, miconazole, clotrimazole, saperconazole, neticonazole, oxiconazole, isoconazole, sulconazole, tercanazole, tioconazole, naftifine, SF86-327, nyastatin, amphotericin B, pimaricin, benzoic acid and salts thereof, sorbic acid and salts thereof, propionic acids and salts thereof, boric acid and salts thereof, dehydroacetic acid, sulphurous and vanillic acids, alkyl esters of pararhydrobenzoic acid, thiomersal, phenylmercuric borate, phenylmercuric acetate and phenylmercuric nitrate, nitromersol, sodium ethylmercurithiosalicylate, benzalkonium chloride, cetylpyridinium chloride, benzethonium chloride, cetyltrimethyl animonium bromide, hydroquinone, pyrocatechol, resorcinol, 4-n-hexyl resorcinol, 3a,4,7,7a-tetrahydro-2-((trichloromethyl)thio)-1H-isoindole-1,3(2H)-dione, benzalkonium chloride, benzethonium chloride, benzyl alcohol, cetylpyridinium chloride, chlorobutanol, dehydroacetic acid, o-phenylphenol, phenol, phenylethyl alcohol, potassium benzoate, potassium sorbate, sodium benzoate, sodium dehydroacetate, sodium propionate, sorbic acid, thimerosal, thymol, chlorothymol, alcohols, chlorobutanol, phenoxy-2-ethanol, benzyl alcohol, β-phenylethyl alcohol, chlorhexidine, 6-acetoxy-2,4-dimethyl-m-dioxane 2,4,4′ trichloro-2′-hydroxy-diphenylether, imidizoldinylether urea compound, bromo-2-nitropropanediol-1,3 5-bromo-5-nitrol-1,3 dioxane, 2-methyl 1-4-isothiazolin-3-one and 5 chloro derivative, 1-(3-chloroallyl)-3,5,7-triazo 1-azoniaadamantane chloride, formaldehyde, imidazolidinyl urea, morpholines, salicylic acids, sodium iodides and potassium iodides, flucytosine, 5-flucytosine, griseofulvin, terbinafine, cidofovir, famicoclovir, valacyclovir, echinocandins, pneumocandins, pradimicins, benanomicins, nikkomycins, amorolfine, polyoxins, duanorubicin citrate, doxorubicin hydrocholride, tolnaftate, cyclopirox, butenafine, ergestrol biosynthesis inhibitors, acrisorein, 3-amino-4-hydroxybutyric acid, ammonium mercuric chloride, amorolfine, anthralin, azaserine, bifonazole, biphenamine, bromosalicyichloranilide, buclosamide, butoconazole, calcium propionate, candicidin, chlordantoin, chlormidazole, chlorphenesin, chlorquinaldol, cloconazole, cloxyquin, coparaffinate, m-cresyl acetate, cupric sulfate, dermostatin, diamthazole dihydrochloride, econazole, enilconazole, etisazol, exalamide, fenticonazole, filipin, flutrimazole, fungichromin, hachimycin, halethazole, hamycin, hexetidine, lanoconazole, loflucarban, lucensomycin, Magenta I, mepartricin, 2-(methoxymethyl)-5-nitrofuran, monensin, myxin, natamycin, neomycin undecylenate, nifuratel, oligomycins, omoconazole, ontianil, pecilocin, perimycin, pyrithione, pyrrolnitrin, rubijervine, salicylanilide, sertaconzole, siccanin, sulbentine, tenonitrozole, tolciclate, tolindate, triacetin, 2,4,6-tribromo-m-cresol, tubercidin, ujothion, undecylenic acid, viridin, and zinc propionate.15. The method of claim 10, wherein the composition further comprises said at least one anti-fungal agent and said at least one anti-fungal agent is selected from the group consisting of cresol, clotrimazole, tolnaftate, terbinafine and tioconazole.16. The method of claim 10, wherein the composition further comprises said at least one anti-fungal agent and said at least one anti-fungal agent is selected from the group consisting of benzoic acid and salts thereof, sorbic acid and salts thereof, propionic acid and salts thereof, boric acid and salts thereof, dehydroacetic acid, sulphurous acids, vanillic acids, phenol, cresol, chlorocresol, o-phenylphenol, chlorothymol, parabens, alkyl esters of parahydroxybenzoic acid, methyl- p-hydroxybenzoates, ethyl- p-hydroxybenzoates, propyl- p-hydroxybenzoates, benzyl- p-hydroxybenzoates and butyl-p-hydroxybenzoates, thimersal, phenylmercuric acetate and phenylmercuric nitrate, nitromersol, sodium ethylmercurithiosalicylate, benzalkonium chloride, cetylpyridium chloride, benzethonium chloride, cetyltrimethyl ammonium bromide, chlorobutanol, phenoxy-2-ethanol, benzyl alcohol, β-phenylethyl alcohol, chlorohexidine, chloroform, 6-acetoxy-2,4-dimethyl-m-dioxane, 2,4,4′ trichloro-2′-hydroxy-diphenylether, imidizolidinyl urea compound, bromo-2nitropropanediol-1,3,5-bromo-5-nitrol-1,3 dioxane, 2-methyl-4-isothiazolin-3-one and 5 chloro derivative, and 1-(3-chloroallyl)-3,5,7-triazo 1-azoniaadamantane chloride.17. The method of claim 10, wherein the composition further comprises said at least one skin care additive and said at least one skin care additive is selected from the group consisting of miconazole nitrate, povidone iodine complex, cliquinol, haloprogin, tolnaftate and undecylenic acid and mixtures thereof.18. The method of claim 10, wherein the at least one anti-fungal agent or skin care additive is mixed with the polymerizable monomer composition immediately prior to applying the polymerizable monomer composition to the area of skin.19. The method of claim 10, wherein the at least one anti-fungal agent or skin care additive is mixed with the polymerizable monomer composition during manufacture of the polymerizable monomer composition.20. The method of claim 10, wherein the composition further comprises said at least one anti-fungal agent and said anti-fungal agent is a phenolic antioxidant.21. The method of claim 20, wherein said antioxidant is a stabilizing agent for said monomer.22. The method of claim 10, wherein the composition further comprises said at least one anti-fungal agent and said anti-fungal agent is butylparaben.23. The method of claim 1, wherein said composition has a Sterility Assurance Level (SAL) of 10?3-10?6.24. The method of claim 1, further comprising applying at least one of an anti-fungal agent or a skin care additive to the area of skin before applying the adhesive composition.25. The method of claim 24, wherein said method is for treating said skin yeast infection, and said area of skin is afflicted with said skin yeast infection.26. The method of claim 24, further comprising allowing the at least one applied anti-fungal agent or skin care additive to substantially dry before applying the adhesive composition.27. The method of claim 24, wherein the anti-fungal agent is applied and is selected from the group consisting of parabens, cresols, and non-polymer-stabilized compounds.28. The method of claim 24, wherein the anti-fungal agent is applied and is selected from the group consisting of alkyl parabens having an alkyl group of from 1-4 carbon atoms.29. The method of claim 24, wherein the anti-fungal agent is applied and is selected from the group consisting of methylparaben, methylparaben sodium, ethylparaben, propylparaben, propylparaben sodium, butylparaben, cresol, chlorocresol, voriconazole, ketoconazole, fluconazole, itraconazole, miconazole, clotrimazole, saperconazole, neticonazole, oxiconazole, isoconazole, sulcopazole, tercanazole, tioconazole, naftifine, SF86-327, nyastatin, amphotericin B, pimaricin, benzoic acid and salts thereof, sorbic acid and salts thereof, propionic acids and salts thereof, boric acid and salts thereof, dehydroacetic acid, sulphurous and vanillic acids, alkyl esters of pararhydrobenzoic acid, thimerosal, phenylmercuric borate, phenylmercuric acetate and phenylmercuric nitrate, nitromersol, sodium ethylmercurithiosalicylate, benzalkonium chloride, benzethonium chloride, benzyl alcohol, cetylpyridinium chloride, chiorobutanol, dehydroacetic acid, o-phenylphenol, phenol, phenylethyl alcohol, potassium benzoate, potassium sorbate, sodium benzoate, sodium dehydroacetate, sodium propionate, sorbic acid, thimerosal, thymol, chlorothymol, alcohols, chlorobutanol, phenoxy-2-ethanol, benzyl alcohol, β-phenylethyl alcohol, chlorhexidine, 6-acetoxy-2,4-dimethyl-m-dioxane 2,4,4′ trichloro-2′-hydroxy-diphenylether, imidizoldinylether urea compound, bromo-2-nitropropanediol-1,3 5-bromo-5-nitrol-1,3 dioxane, 2-methyl 1-4-isothiazolin-3-one and 5 chloro derivative, 1-(3-chloroallyl)-3,5,7-triazo 1-azoniaadamantane chloride and formaldehyde, imidazolidinyl urea, morpholines, salicylic acids, sodium iodides, potassium iodides, flucytosine, 5-flucytosine, griseofulvin, terbinafine, cidofovir, famicoclovir, valacyclovir, echinocandins, pneumocandins, pradimicins, benanomicins, nikkomycins, amorolfine, polyoxins, duanorubicin citrate, doxorubicin hydrocholride, tolnaftate, ciclopirox, butenafine, ergestrol biosynthesis inhibitors, acrisorein, 3-amino-4-hydroxybutyric acid, ammonium mercuric chloride, amorolfine, anthralin, azaserine, bifonazole, biphenamine, bromosalicylchloranilide, buclosamide, butoconazole, calcium propionate, candicidin, chlordantoin, chlormidazole, chlorphenesin, chlorquinaldol, cloconazole, cloxyquin, coparaffinate, m-cresyl acetate, cupric sulfate, dermostatin, diamthazole dihydrochloride, econazole, enilconazole, etisazol, exalamide, fenticonazole, filipin, flutrimazole, fungichromin, hachimycin, halethazole, hamycin, hexetidine, lanoconazole, loflucarban, lucensomycin, Magenta I, mepartricin, 2-(methoxymethyl)-5-nitrofuran, monensin, myxin, natamycin, neomycin undecylenate, nifuratel, oligomycins, omoconazole, ontianil, pecilocin, perimycin, pyrithione, pyrrolnitrin, rubijervine, salicylanilide, sertaconzole, siccanin, sulbentine, tenonitrozole, tolciclate, tolindate, triacetin, 2,4,6-tribromo-m-cresol, tubercidin, ujothion, undecylenic viridin, and zinc propionate.30. The method of claim 30, wherein the anti-fungal agent is applied and is selected from the group consisting of elemental metals and metal compounds.31. The method of claim 24, wherein the anti-fungal agent is applied and further comprises at least one of a diluent and a carrier.32. The method of claim 24, wherein the anti-fungal agent is applied and is in the form of a liquid, a solid, a powder, or a cream.33. The method of claim 24, wherein the skin care additive is applied and is selected from the group consisting of miconazole nitrate, povidone iodine complex, cliquinol, haloprogin, tolnaftate and undecylenic acid and mixtures thereof.34. The method of claim 1, wherein said adhesive composition is applied directly to said area of skin, and said adhesive composition does not include an anti-fungal agent or a skin care additive.35. The method of claim 34, wherein said polymer film has anti-fungal effects at said area of skin.36. The method of claim 1, wherein said area of skin is selected from the group consisting of around skin folds, in a groin area, in a buttock area, on a trunk, under a breasts, and in an arm pit.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (70)
Narang Upvan ; Nicholson William S. C., 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane.
Lucast Donald H. (North St. Paul MN) Calhoun Clyde D. (Stillwater MN) Riedel John E. (Hugo MN) Taylor Charles W. (Lake Elmo MN), Adhesive sheet material suitable for use on wet surfaces.
Badejo, Ibraheem; Hedgpeth, Daniel L.; Narang, Upvan; Nicholson, William S. C.; Rivera, Andres; Rivera, Mary Jo S.; Sherbondy, Anthony; Szabo, Gabriel N., Adhesive treatment for tinea pedis.
Akimova Alla Y. (ulitsa Petrozavodskaya ; 5 ; korpus 3 ; kv. 391 Moscow SUX) Davydov Anatoly B. (ulitsa Krasny Kazanets ; 19 ; korpus 1 ; kv. 283 Moscow SUX) Egiev Valery N. (Volgogradsky prospekt ; , Biocompatible material for treatment of tissular or organic defects.
Akimova Alla Y. (Moscow SUX) Buyanov Valentin M. (Moscow SUX) Galperin Eduard I. (Moscow SUX) Davydov Anatoly B. (Moscow SUX) Derkach Galina M. (Moscow SUX) Derevyanko Vitaly P. (Moscow SUX) Keshelav, Composition for sealing wound surfaces.
Greff Richard J. (Yorba Linda CA) Tighe Patrick J. (Littleton CO) Byram Michael M. (Colorado Springs CO) Barley Leonard V. (Colorado Springs CO), Cyanoacrylate adhesive compositions.
Greff Richard J. (Yorba Linda CA) Tighe Patrick J. (Littleton CO) Byram Michael M. (Colorado Springs CO) Barley Leonard V. (Colorado Springs CO), Cyanoacrylate adhesive compositions.
Melanson David A. ; Sawhney Amarpreet S. ; Levine Marc Alan ; Spiridigliozzi John C. ; Bromander Thomas S., Initiator priming for improved adherence of gels to substrates.
Tighe Patrick J. (Littleton CO) Byram Michael M. (Colorado Springs CO) Barley ; Jr. Leonard V. (Colorado Springs CO), Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives.
Barley ; Jr. Leonard V. (Colorado Springs CO) Tighe Patrick J. (Littleton CO) Greff Richard J. (Yorba Linda CA) Byram Michael M. (Colorado Springs CO), Methods for reducing skin irritation from artificial devices by use of cyanoacrylate adhesives.
Greff Richard J. ; Byram Michael M., Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimi.
Barley Linda M. (Colorado Springs CO) Renfrow J. Royce (Mt. Crested Butte CO) Byram Michael (Colorado Springs CO), Methods for treating suturable wounds by use of sutures and cyanoacrylate adhesives.
Berglund Claire A. (Shoreview MN) Rosso Paul D. (St. Joseph Township ; St. Croix County WI), Pressure-sensitive adhesive having a broad spectrum antimicrobial therein.
McDonnell Patrick F. (Dublin IEX) Lambert Robert J. (County Dublin IEX), Sterilized cyanoacrylate adhesive composition, and a method of making such a composition.
Byram Michael M. (Colorado Springs CO) Goebel Robert (Huntington Beach CA) Greff Richard J. (Yorba Linda CA) Barley ; Jr. Leonard V. (Littleton CO), Use of cyanoacrylate adhesive compositions to inhibit acute radiation-induced skin damage.
Tighe Patrick J. (Littleton CO) Greff Richard J. (Yorba Linda CA) Byram Michael M. (Colorado Springs CO) Barley Leonard V. (Colorado Springs CO), Use of cyanoacrylate adhesives for providing a protective barrier film for the skin.
Chvapil Milos (Tucson AZ) Hoenig Stuart A. (Tucson AZ), Use of hydrogel solutions to form a hydrophilic protective film on the skin against toxic substances, pollutants, infect.
Zhang, Sheng; Ruiz, Rafael, Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator.
Burrell, Janna M.; Byrum, Randal T.; Koch, Jr., Robert Louis; Pool, Larry D.; Widenhouse, Christopher W., Methods and devices for treating morbid obesity using hydrogel.
Faller, Craig N.; Haberstitch, Wells D.; Korvick, Donna L.; Thompson, Bennie; Turner, Douglas J.; Nalagatla, Anil K.; Shelton, IV, Frederick E., Use of an adhesive to treat intraluminal bleeding.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.